Cargando…
Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma
PURPOSE: Although gemcitabine-based chemotherapy is most recommended for pancreatic ductal adenocarcinoma (PDAC), its effectiveness is limited because of drug resistance. Given thalidomide’s anti-tumor effects in solid tumors, we investigated the effect of avadomide, a novel thalidomide analog, on P...
Autores principales: | Nishi, Hidemi, Gotoh, Kunihito, Tomimaru, Yoshito, Kobayashi, Shogo, Sasaki, Kazuki, Iwagami, Yoshifumi, Yamada, Daisaku, Akita, Hirofumi, Asaoka, Tadafumi, Noda, Takehiro, Takahashi, Hidenori, Tanemura, Masahiro, Doki, Yuichiro, Eguchi, Hidetoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435408/ https://www.ncbi.nlm.nih.gov/pubmed/37491611 http://dx.doi.org/10.1007/s00280-023-04531-w |
Ejemplares similares
-
Tumor endothelial cell‐induced CD8(+) T‐cell exhaustion via GPNMB in hepatocellular carcinoma
por: Sakano, Yoshihiro, et al.
Publicado: (2022) -
Prognostic value of functional SMAD4 localization in extrahepatic bile duct cancer
por: Takayama, Hirotoshi, et al.
Publicado: (2022) -
MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
por: Mikamori, Manabu, et al.
Publicado: (2017) -
Successful endovascular embolization of the common hepatic artery for pseudoaneurysm associated with pancreatic fistula after liver transplantation: a case report
por: Sasaki, Kazuki, et al.
Publicado: (2023) -
Serum exosomal miR‐638 is a prognostic marker of HCC via downregulation of VE‐cadherin and ZO‐1 of endothelial cells
por: Yokota, Yuki, et al.
Publicado: (2021)